• InpharmD

  Participated · Seed · Dec 2023

  InpharmD provides an AI-based drug information service that pairs pharmacists' expertise with large language models to deliver custom, data-driven responses to clinical questions and formulary requests. The product supports cost-efficient decision-making by recommending therapeutic interchanges and protocols intended to reduce patient hospital stays. It partners with 11 health systems and integrates with platforms like Alexa and Epic to deliver answers at point of care. The company assists over 100 hospitals and 10,000 clinicians, performing literature searches that save about two hours and summarize roughly 12 clinical studies per search. Over two years InpharmD has curated a database of 30 million clinical studies and uses a blend of proprietary and open-source LLMs to search and summarize relevant literature. Reinforcement learning is performed by clinical pharmacists to refine searches and summaries and to improve the algorithm for subsequent queries. The company raised $6.05M and intends to use the funds to expand operations and broaden its business reach.

No current team members are available.